Anti-inflammatory, anthropometric and lipomodulatory effects Dyglomera® (aqueous extract of Dichrostachys glomerata) in obese patients with metabolic syndrome

Functional Foods in Health and Disease

Volumn 3, Issue 11, 2013, Pages 416-427

  Kuate, Dieudonne ^a,b,d   Etoundi, Blanche C ^a,c   Ngondi, Judith L ^a   Muda, Wan Abdul Manan Bin Wan ^d   Oben, Julius E ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b UNIVERSITY OF DSCHANG   (Cameroon)

^c UNIVERSITY OF DOUALA   (Cameroon)

^d SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Dichrostachys glomerata extract; Inflammation; Metabolic syndrome; Obesity

Indexed keywords

EID: 84930199346     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v3i11.35     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
3. Ritchie SA, Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metabol Cardiovasc Dis 2007; 17:319-26.
4. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116:1784-92.
5. Galiste M, Duarte J, Zarzuel A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 2008; 19:71-84.
6. Valsamakis G, McTernan P, Chetty R, Al Daghri N, Field A, Hanif W, Barnett A, and Kumar S. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53:430-34.
7. National Task Force on the Prevention and Treatment of Obesity. Long term pharmacotherapy in the management of obesity. JAMA 1996; 276:1907-15.
8. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB. Sibutramine produces dose-related weight loss. Obes Res Relat Metab Disord 1999; 7:189-98.
9. Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M. for The European Multicentre Orlistat Study Group. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients Lancet 1998; 352:167-72.
10. Pari L, Umamaheswari J. Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytother Res 2000; 14:1-3.
11. Valiathan MS, Healing plants. Current Science 1998; 75:1122-27.
12. Tchiégang C, Mbougueng PD. Chemical composition of spices used in the cooking of nah poh and nkui of western Cameroon. Tropicultura 2005; 23:193-200.
13. Roth LW, Keller F, U.S. Patent 3,089,817, 1963.
14. Fankam AG, Kuete V, Voukeng IK, Kuiate JR, Pages JM. Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes. BMC Complementary and Alternative Medicine 2011; 11:104. doi:10.1186 /1472-6882-11- 104.
15. Atsang AKG, Dzeufiet DPD, Foyet HS, Nana P, Sokeng DS, Dimo T, Kamtchouing P. Analgesic and Anti-Inflammatory Activities of Dichrostachys glomerata (Forssk.) Hutch. Fruits Methanolic Extract in Rats. J Phys Pharm Adv 2012; 2(8): 269-276
16. Kudi AC, Umoh JU, Eduvie LO, Gefu J. Screening of some Nigerian Medicinal plants for antibacterial activity. J Ethnopharm 1999; 67(2): 225-228.
17. Kuate D, Etoundi BCO, Soukontoua YB, Ngondi JL, Oben JE. Antioxidant characteristics of Dichrostachys glomerata spice extracts. CYTA-Journal of Food 2010; 8:23-37.
18. Kuate, D. Effects of some spices on glucose and lipid metabolism and oxidative stress. Ph.D. Thesis, University of Yaounde, Yaounde, Cameroon. 2010.
19. Kuate D, Etoundi BC, Ngondi JL, Oben JE. Effects of Dichrostachys glomerata spice on cardiovascular diseases risk factors in normoglycemic and type 2 diabetic obese volunteers. Food Res Int 2011; 44:1197-02.
20. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
21. Trinder P. determination of blood glucose using 4-amino- phenazone as oxygen acceptor. J Clin Pathol 1969; 22: 158-61.
22. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum Clin Chem 1973; 19:1350-56.
23. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19:476-82.
24. Bachorik PS, Wood PD, Albers JJ, Steiner P, Dempsey M, Kuba K, Karlsson L. Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation. Clin Chem 1976; 22: 1928-34.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-02.
26. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26:2442-50.
27. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 2001;103:1057-63.
28. Matsushita K, Ishikawa T, Sumita S, Kobayashi T, Ogawa H, Inoue N, Katsumi Matsumoto K. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26:871-6.
29. Gazi I, Liberopoulos EN, Mikhailidis DP, Elisaf M. Metabolic Syndrome: Clinical Features Leading to Therapeutic Strategies. Vasc Dis Prev 2004; 1:243-53.
30. Brunzell JD, Hokanson JE. Dyslipidemia of central obesity and insulin resistance. Diabetes Care 1999; 22:C10-C13.
31. Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP. Management of high triglycerides: What non specialists in lipids need to know. Hell J Cardiol 2005; 46:268-72.
32. Bairaktari ET, Seferiadis KI, Elisaf M. Evaluation of methods for the measurement of low-density lipoprotein cholesterol. J Cardiovasc Pharmacol Therapeut 2005; 10:45-54.